Neurovalens
Manufacturing · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
7 James St South Fl 4, Belfast, BT2 8DN,...Website
www.neurovalens.comRevenue
$6.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Neurovalens
Founded in 2015, Neurovalens is a global health-tech company that creates non-invasive neurostimulation products. The company is headquartered in Belfast, Ireland.Explore more
Neurovalens Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Neurovalens your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Neurovalens, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if Neurovalens is spiking on competitors!
Click to see if Neurovalens had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Neurovalens has new funding data
Earning: See what the market has to say on Neurovalens recently announced quarterly report
Product Launch: Get notified when Neurovalens launches new products
Check if Neurovalens has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Neurovalens
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Neurovalens is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Neurovalens is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Neurovalens.
Neurovalens financials insights
Gather financial insights about Neurovalens, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Series A
$6M
2020
Unspecified
$6.4M
Other Financing Round
$3.6M
2021
Unspecified
$298K
2024
Other Financing Round
$2.6M
2025
Debt
$1.4M
Other Financing Round
$6.8M
Neurovalens Tech Stack
A closer look at the technologies used by Neurovalens
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Event
Person-Based
Thomas Bilyeu, Advisor, appeared on a podcast called "Tom Bilyeu's Mindset Playbook" on 12/11/2025. Topics discussed include Social Anxiety, Accountability, Mindset.
Events, Podcast
Event
Product Marketing, Events, Sales, Logistics / Supply Chain, Field Marketing, Healthcare Operations, Healthcare Technology, Medical Administration, Operations
Funding
Funding
Funding
Funding
Neurovalens News & Media
Neurovalens Expands Access to Modius Sleep for Veterans Through U.S. Department of Veterans Affairs (VA) Program
BELFAST, Northern Ireland, Feb. 24, 2025 /PRNewswire/ -- Neurovalens, a global leader in noninvasive neurostimulation technology, is making significant strides in addressing chronic insomnia among U.S. veterans. The company's FDA-cleared, drug-free insomnia treatment device, Modius Sleep,...Product Launch: Modius Sleep FDA-Cleared Non-Invasive Device that Treats Chronic Insomnia is Now Available for Purchase
95 percent of clinical trial participants reported better sleep in four weeks BELFAST, Northern Ireland, Oct. 28, 2024 /PRNewswire/ -- Neurovalens, a global health-tech leader in neurotechnology, has launched its first product, Modius Sleep, to treat chronic insomnia. Neurovalens received...7 neurotech companies you need to know
Neurotech is going far beyond just using pacemaker-like devices to treat the brain and nervous system. Here are seven companies to know.Neurovalens Appoints Kate Willis as Vice President of Commercialization
Neurovalens, a global leader in non-invasive neuro-technology, has today announced the appointment of experienced MedTech professional Kate Willis to drive its growth in the US market. BELFAST, Northern Ireland, June 5, 2024 /PRNewswire-PRWeb/ -- Neurovalens, a global leader in...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Neurovalens
Sign Up For FreeTo access detailed company insights
Founded in 2015, Neurovalens is a global health-tech company that creates non-invasive neurostimulation products. The company is headquartered in Belfast, Ireland.... Read More
